A folylpoly-γ-glutamate synthase single nucleotide polymorphism associated with response to pemetrexed treatment combined with platinum for non-small cell lung cancer
Keywords: گارد; SNP; single nucleotide polymorphism; FPGS; folylpoly-γ-glutamate synthase; PEM; pemetrexed; MTX; methotrexate; NSCLC; non-small cell lung cancer; Bev; bevacizumab; TS; thymidylate synthase; DHFR; dihydrofolate reductase; GARFT; glycinamide ribonucleotide